Nabumetone
- Product NDC
- 50090-6167
- 11-digit product format
- 500906167
- Labeler code
- 50090
- Product ID
- 50090-6167_ae902cbe-e8b4-42c9-8e85-828d7ca2d2f6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA078420
- Marketing category
- ANDA
- Marketing start
- 2019-06-26
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| LW0TIW155Z | NABUMETONE | 42924-53-8 | NABUMETONE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6167-0 | 50090616700 | 30 TABLET in 1 BOTTLE (50090-6167-0) | 30 tablet | 2022-10-13 | No | No | Historical |
| 50090-6167-2 | 50090616702 | 14 TABLET in 1 BOTTLE (50090-6167-2) | 14 tablet | 2022-10-13 | No | No | Historical |
| 50090-6167-3 | 50090616703 | 60 TABLET in 1 BOTTLE (50090-6167-3) | 60 tablet | 2022-10-13 | No | No | Historical |
| 50090-6167-4 | 50090616704 | 20 TABLET in 1 BOTTLE (50090-6167-4) | 20 tablet | 2022-10-13 | No | No | Historical |